Charles Schwab’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $81.5M | Buy |
1,217,496
+26,808
| +2% | +$1.96M | 0.01% | 910 |
|
|
2026
Q1 | $90.9M | Buy |
1,190,688
+69,137
| +6% | +$4.98M | 0.01% | 778 |
|
|
2025
Q4 | $71.6M | Sell |
1,121,551
-90,527
| -7% | -$5.58M | 0.01% | 920 |
|
|
2025
Q3 | $76.4M | Buy |
1,212,078
+32,470
| +3% | +$2.27M | 0.01% | 866 |
|
|
2025
Q2 | $88.1M | Buy |
1,179,608
+38,719
| +3% | +$3.04M | 0.02% | 737 |
|
|
2025
Q1 | $101M | Sell |
1,140,889
-1,399
| -0.1% | -$132K | 0.02% | 649 |
|
|
2024
Q4 | $104M | Buy |
1,142,288
+10,420
| +0.9% | +$1.07M | 0.02% | 643 |
|
|
2024
Q3 | $127M | Sell |
1,131,868
-3,465
| -0.3% | -$347K | 0.02% | 541 |
|
|
2024
Q2 | $111M | Buy |
1,135,333
+12,121
| +1% | +$1.2M | 0.02% | 592 |
|
|
2024
Q1 | $113M | Buy |
1,123,212
+14,525
| +1% | +$1.28M | 0.03% | 547 |
|
|
2023
Q4 | $99.6M | Buy |
1,108,687
+29,557
| +3% | +$2.36M | 0.03% | 563 |
|
|
2023
Q3 | $82.8M | Buy |
1,079,130
+19,450
| +2% | +$1.61M | 0.02% | 589 |
|
|
2023
Q2 | $88.7M | Buy |
1,059,680
+10,776
| +1% | +$876K | 0.03% | 567 |
|
|
2023
Q1 | $88.5M | Buy |
1,048,904
+10,897
| +1% | +$936K | 0.03% | 555 |
|
|
2022
Q4 | $84.5M | Buy |
1,038,007
+21,107
| +2% | +$1.7M | 0.03% | 545 |
|
|
2022
Q3 | $72.3M | Sell |
1,016,900
-16,596
| -2% | -$1.49M | 0.03% | 567 |
|
|
2022
Q2 | $92.8M | Buy |
1,033,496
+15,005
| +1% | +$1.55M | 0.03% | 476 |
|
|
2022
Q1 | $114M | Sell |
1,018,491
-2,958
| -0.3% | -$347K | 0.03% | 466 |
|
|
2021
Q4 | $124M | Buy |
1,021,449
+22,189
| +2% | +$2.47M | 0.04% | 446 |
|
|
2021
Q3 | $101M | Buy |
999,260
+15,899
| +2% | +$1.75M | 0.03% | 481 |
|
|
2021
Q2 | $115M | Buy |
983,361
+24,830
| +3% | +$2.98M | 0.04% | 438 |
|
|
2021
Q1 | $106M | Sell |
958,531
-1,333,644
| -58% | -$145M | 0.04% | 425 |
|
|
2020
Q4 | $230M | Buy |
2,292,175
+168,096
| +8% | +$15.6M | 0.09% | 200 |
|
|
2020
Q3 | $166M | Buy |
2,124,079
+59,963
| +3% | +$4.52M | 0.08% | 230 |
|
|
2020
Q2 | $144M | Buy |
2,064,116
+527,002
| +34% | +$33.2M | 0.07% | 251 |
|
|
2020
Q1 | $71.6M | Buy |
1,537,114
+79,240
| +5% | +$5.09M | 0.04% | 393 |
|
|
2019
Q4 | $116M | Buy |
1,457,874
+25,397
| +2% | +$1.95M | 0.06% | 283 |
|
|
2019
Q3 | $106M | Buy |
1,432,477
+309,941
| +28% | +$22.2M | 0.06% | 290 |
|
|
2019
Q2 | $87.4M | Buy |
1,122,536
+50,097
| +5% | +$3.81M | 0.05% | 345 |
|
|
2019
Q1 | $81.4M | Buy |
1,072,439
+56,168
| +6% | +$4.46M | 0.05% | 348 |
|
|
2018
Q4 | $74.3M | Buy |
1,016,271
+55,766
| +6% | +$4.45M | 0.06% | 312 |
|
|
2018
Q3 | $91.9M | Buy |
960,505
+36,360
| +4% | +$3.61M | 0.06% | 290 |
|
|
2018
Q2 | $92.4M | Sell |
924,145
-76,372
| -8% | -$8.06M | 0.07% | 268 |
|
|
2018
Q1 | $106M | Buy |
1,000,517
+343,606
| +52% | +$34.7M | 0.08% | 236 |
|
|
2017
Q4 | $60.9M | Buy |
656,911
+26,085
| +4% | +$2.37M | 0.05% | 364 |
|
|
2017
Q3 | $57.1M | Buy |
630,826
+48,311
| +8% | +$4.11M | 0.05% | 357 |
|
|
2017
Q2 | $48.9M | Buy |
582,515
+38,018
| +7% | +$3.06M | 0.05% | 400 |
|
|
2017
Q1 | $44M | Buy |
544,497
+95,856
| +21% | +$7.54M | 0.04% | 409 |
|
|
2016
Q4 | $33.7M | Buy |
448,641
+19,496
| +5% | +$1.41M | 0.04% | 482 |
|
|
2016
Q3 | $29M | Buy |
429,145
+4,739
| +1% | +$318K | 0.03% | 517 |
|
|
2016
Q2 | $28.8M | Buy |
424,406
+10,508
| +3% | +$772K | 0.04% | 491 |
|
|
2016
Q1 | $29.9M | Buy |
413,898
+6,524
| +2% | +$427K | 0.04% | 457 |
|
|
2015
Q4 | $27.5M | Buy |
407,374
+17,128
| +4% | +$1.2M | 0.04% | 469 |
|
|
2015
Q3 | $25.3M | Buy |
390,246
+3,187
| +0.8% | +$235K | 0.04% | 460 |
|
|
2015
Q2 | $31.7M | Buy |
387,059
+12,240
| +3% | +$944K | 0.04% | 411 |
|
|
2015
Q1 | $26M | Buy |
374,819
+13,668
| +4% | +$987K | 0.04% | 465 |
|
|
2014
Q4 | $27.4M | Buy |
361,151
+12,090
| +3% | +$956K | 0.04% | 420 |
|
|
2014
Q3 | $28.2M | Buy |
349,061
+7,190
| +2% | +$600K | 0.05% | 386 |
|
|
2014
Q2 | $29.9M | Buy |
341,871
+7,689
| +2% | +$668K | 0.05% | 367 |
|
|
2014
Q1 | $28.8M | Buy |
334,182
+2,347
| +0.7% | +$192K | 0.05% | 357 |
|
|
2013
Q4 | $26.8M | Buy |
331,835
+8,701
| +3% | +$676K | 0.05% | 353 |
|
|
2013
Q3 | $25.7M | Buy |
323,134
+3,808
| +1% | +$293K | 0.05% | 343 |
|
|
2013
Q2 | $22.8M | Buy |
+319,326
| New | +$22.3M | 0.05% | 352 |
|
Other funds holding EMN
Charles Schwab's EMN Position: Q2 2026 in Review
Charles Schwab increased its Eastman Chemical (EMN) stake by 2.3% in Q2 2026, buying an estimated $1.96M and bringing the position to 1,217,496 shares worth $81.5M. The position accounts for 0.01% of the portfolio, ranked #910.
Charles Schwab first reported a position in EMN in Q2 2013 and has held it in 53 quarters since. The position peaked at $230M in Q4 2020. 640 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Charles Schwab held 1,217,496 shares of Eastman Chemical worth $81.5M as of Q2 2026.
- Charles Schwab bought 26,808 Eastman Chemical shares in Q2 2026, an estimated $1.96M.
- Eastman Chemical made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #910 holding.
- Charles Schwab first reported a position in Eastman Chemical in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Eastman Chemical position peaked at $230M in Q4 2020.
- 640 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.